
Consultant neurologist specializing in stroke care and cerebrovascular disease
Experience
4 years
Languages
English
Location
UAE
Sees
adults, seniors
Dr. Suhail Abdulla Mohammad Alruknl is a consultant neurologist with over 10 years of clinical experience. He completed his fellowship in cerebral vascular disease and stroke at McGill University in Canada, and currently practices at Saudi German Hospital where he leads the neurology department's stroke unit.
Dr. Alruknl specializes in the diagnosis and treatment of all types of stroke, with particular expertise in acute stroke management. His stroke unit provides time-sensitive care for patients presenting within the critical treatment window (first 3 hours after symptom onset), offering thrombolytic therapy and comprehensive medical management for stroke patients.
He holds leadership positions in regional and international neurology organizations, serving as President of the Emirates Neurology Society and Chairman of the MENA Stroke Initiative. This reflects his commitment to advancing stroke care standards and neurological practice across the Middle East and North Africa region.
Special interests: stroke management, cerebrovascular disease, regional neurology standards.
Extracted from the doctor's hospital profile — patient-friendly terms
Fellowship in Cerebral Vascular Disease and Stroke
McGill University, Canada
Consultant Neurologist
Saudi German Hospital, United Arab Emirates
Consultations are available in English.
This doctor primarily sees adults and seniors.
Commonly treated: Acute Ischemic Stroke, Cerebrovascular Disease, Hemorrhagic Stroke, Stroke, Transient Ischemic Attack (Tia).
Profile compiled from Saudi German Hospital's public website (see original profile via the booking link). Data is informational, not medical advice.
No patient reviews yet — be the first.
Visited Dr. Suhail Abdulla Mohammad Alruknl? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.